Vanguard Group Inc. Raises Stock Position in HealthEquity, Inc. $HQY

Vanguard Group Inc. increased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,746,255 shares of the company’s stock after buying an additional 243,549 shares during the quarter. Vanguard Group Inc. owned 10.15% of HealthEquity worth $828,883,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HQY. Caitong International Asset Management Co. Ltd purchased a new stake in shares of HealthEquity during the second quarter worth about $33,000. True Wealth Design LLC boosted its stake in HealthEquity by 3,522.2% in the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after purchasing an additional 317 shares in the last quarter. Cullen Frost Bankers Inc. grew its position in HealthEquity by 172.3% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after purchasing an additional 224 shares during the last quarter. Farther Finance Advisors LLC increased its stake in HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock valued at $37,000 after purchasing an additional 146 shares in the last quarter. Finally, AlphaQuest LLC raised its holdings in shares of HealthEquity by 52.2% in the third quarter. AlphaQuest LLC now owns 624 shares of the company’s stock worth $59,000 after buying an additional 214 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. BTIG Research dropped their price objective on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Barrington Research reissued an “outperform” rating and issued a $125.00 price objective on shares of HealthEquity in a report on Thursday, December 4th. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Monday, January 19th. Finally, Jefferies Financial Group set a $108.00 price target on shares of HealthEquity in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $113.87.

HealthEquity Stock Up 0.0%

Shares of HQY stock opened at $78.89 on Monday. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $116.65. The stock has a market cap of $6.74 billion, a P/E ratio of 36.19, a P/E/G ratio of 0.98 and a beta of 0.24. The stock has a 50 day moving average of $86.55 and a 200 day moving average of $91.68. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. During the same quarter last year, the company earned $0.78 EPS. The business’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, sell-side analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.